Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Molecular Cancer Therapeutics
|
August 12, 2005
The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1
Mi-Ae Lyu, Michael G Rosenblum
Biochemical Pharmacology
|
December 18, 2007
The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines
Mi-Ae Lyu, Razelle Kurzrock, Michael G Rosenblum
Methods in Enzymology
|
January 3, 2012
Cell-targeting fusion constructs containing recombinant gelonin
Mi-Ae Lyu, Yu Joshua Cao, Khalid A Mohamedali, et al.
Blood
|
November 23, 2006
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells
Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du, et al.
Frontiers in Transplantation
|
December 26, 2024
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
Ke Zeng, Hongbing Ma, Meixian Huang, et al.
Iscience
|
September 24, 2024
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation
Meixian Huang, Zeng Ke, Mi-Ae Lyu, et al.
Molecular Imaging and Biology
|
August 6, 2010
Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma
Xiaoxia Wen, Mi-Ae Lyu, Rui Zhang, et al.
Frontiers in Immunology
|
February 20, 2025
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
Mi-Ae Lyu, Ximing Tang, Maria Gabriela Raso, et al.
Molecular Cancer Therapeutics
|
February 3, 2007
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA
Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
Cancer Letters
|
March 6, 2012
Bax345/BLyS: a novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin
Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Molecular Cancer Therapeutics
|
August 12, 2005
The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1
Mi-Ae Lyu, Michael G Rosenblum
Biochemical Pharmacology
|
December 18, 2007
The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines
Mi-Ae Lyu, Razelle Kurzrock, Michael G Rosenblum
Methods in Enzymology
|
January 3, 2012
Cell-targeting fusion constructs containing recombinant gelonin
Mi-Ae Lyu, Yu Joshua Cao, Khalid A Mohamedali, et al.
Blood
|
November 23, 2006
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells
Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du, et al.
Frontiers in Transplantation
|
December 26, 2024
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
Ke Zeng, Hongbing Ma, Meixian Huang, et al.
Iscience
|
September 24, 2024
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation
Meixian Huang, Zeng Ke, Mi-Ae Lyu, et al.
Molecular Imaging and Biology
|
August 6, 2010
Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma
Xiaoxia Wen, Mi-Ae Lyu, Rui Zhang, et al.
Frontiers in Immunology
|
February 20, 2025
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
Mi-Ae Lyu, Ximing Tang, Maria Gabriela Raso, et al.
Molecular Cancer Therapeutics
|
February 3, 2007
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA
Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
Cancer Letters
|
March 6, 2012
Bax345/BLyS: a novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin
Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, et al.
Page
of 2